ASLAN Pharmaceuticals Limited Gains 160.8%
Mon, Mar 11, 2024 at 07:16 PM
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) jumped higher at $1.63, a gain of 160.8%. On Mon, Mar 11, 2024, ASLN:NASDAQ hit a New 2-Week High of $1.63. The stock got featured on our News Catalysts scanner on Mon, Mar 11, 2024 at 10:09 AM in the 'INVESTOR UPDATE' category. From Mon, Feb 26, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- Power & Digital Infrastructure Acquisition II Corp. (XPDB:NASDAQ), 181.44%
- SeaChange International, Inc. (SEAC:NASDAQ), 174.29%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 160.8%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Solidion Technology Inc. (STI:NASDAQ), 124.36%
- Kidpik Corp. (PIK:NASDAQ), 80.37%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 61.32%
- The L.S. Starrett Company (SCX:NYSE), 58.87%
- Energem Corp (ENCP:NASDAQ), 42.3%
- Finch Therapeutics Group Inc. (FNCH:NASDAQ), 36.73%